Form 4 KRATOS DEFENSE & SECURIT For: May 21 Filed by: Zegart Amy
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 RADIAN GROUP INC For: May 22 Filed by: Leyden Margaret Anne
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Accel Entertainment, For: May 21 Filed by: Rubenstein Andrew H.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Accel Entertainment, For: May 22 Filed by: Harmer Derek
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form SC 13G/A GT Biopharma, Inc. Filed by: BRISTOL INVESTMENT FUND LTD
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934 (Amendment No. 17)*
GT Biopharma, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
36254L100
(CUSIP Number)
Amy Wang, Esq.
Bristol Capital Advisors, LLC
555 Marin Street, Suite 140, Thousand Oaks, CA 91360
(310) 331-8485
(Name, Address and Telephone Number of Person Authorized... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 KRATOS DEFENSE & SECURIT For: May 21 Filed by: Jarvis Scot B
-
Form 4 BEYOND, INC. For: May 21 Filed by: LEMONIS MARCUS
-
Form 4 RADIAN GROUP INC For: May 22 Filed by: HESS DEBRA ANN
-
Form 4 ReWalk Robotics Ltd. For: May 21 Filed by: Jasinski Lawrence J
-
Form 4 KRATOS DEFENSE & SECURIT For: May 21 Filed by: HOGLUND WILLIAM A
-
Form 4 RADIAN GROUP INC For: May 22 Filed by: Hess Lisa W
-
Form 4 ALLIANCEBERNSTEIN HOLDIN For: May 22 Filed by: LAMMTENNANT JOAN M
-
Form 4/A GAIA, INC For: May 20 Filed by: Sutherland Paul Howard
-
Form 4 Uber Technologies, Inc For: May 22 Filed by: Trujillo David
-
Form 4 BEYOND, INC. For: May 21 Filed by: TABACCO JOSEPH J JR
-
Form 4 RADIAN GROUP INC For: May 22 Filed by: Ahmad Fawad
-
Form 4 BEYOND, INC. For: May 21 Filed by: Corbus Barclay F
-
Form 4 BEYOND, INC. For: May 21 Filed by: Nettles William Benjamin JR
-
Form 4 Inspired Entertainment, For: May 21 Filed by: WEIL A LORNE
-
Form 4 KRATOS DEFENSE & SECURIT For: May 21 Filed by: Hagen Daniel J
-
Form 4 BEYOND, INC. For: May 21 Filed by: Burkey Joanna Catherine
-
Form 4 OPKO HEALTH, INC. For: May 23 Filed by: FROST PHILLIP MD ET AL
-
Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: Walsh Patrick D
-
Form 4 BEYOND, INC. For: May 21 Filed by: Nielsen David J.
-
Form 4 DraftKings Inc. For: May 21 Filed by: Robins Jason
-
Form 4 DraftKings Inc. For: May 22 Filed by: Liberman Paul
-
Form 4 Payoneer Global Inc. For: May 22 Filed by: Goldman Tsafi
-
Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: Thoma Jeanne
-
Form 4 SAUL CENTERS, INC. For: May 17 Filed by: Leffall LaSalle D. III
-
Form 4 DraftKings Inc. For: May 22 Filed by: Dodge R Stanton
-
Form 4 Payoneer Global Inc. For: May 21 Filed by: Perry Itai
-
Form 4 DraftKings Inc. For: May 22 Filed by: Kalish Matthew
-
Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: TANNENBAUM RENEE P
-
Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: Pera Antonio R
-
Form 4 VirnetX Holding Corp For: May 21 Filed by: Larsen Kendall
-
Form 4 MICRON TECHNOLOGY INC For: May 21 Filed by: MEHROTRA SANJAY
-
Form 4 Forge Global Holdings, For: May 22 Filed by: Rodriques Kelly
-
Form 4 ANI PHARMACEUTICALS INC For: May 21 Filed by: Leonard Matthew J
-
Form 4 10x Genomics, Inc. For: May 22 Filed by: McAnear Justin J.
-
Form 4 10x Genomics, Inc. For: May 22 Filed by: Saxonov Serge
-
Form 4 10x Genomics, Inc. For: May 22 Filed by: Hindson Benjamin J.
-
Form 4 STEVEN MADDEN, LTD. For: May 22 Filed by: LYNCH ROSE PEABODY
-
Form 4 STEVEN MADDEN, LTD. For: May 22 Filed by: Davis Peter Allan
-
Form 4 STEVEN MADDEN, LTD. For: May 22 Filed by: Kumar Maria Teresa
-
Form 4 STEVEN MADDEN, LTD. For: May 22 Filed by: MIGLIORINI PETER
-
Form 4 STEVEN MADDEN, LTD. For: May 22 Filed by: Reed Arian Simone
-
Form 4 STEVEN MADDEN, LTD. For: May 22 Filed by: Ferrara Al
-
Form 4 STEVEN MADDEN, LTD. For: May 22 Filed by: Sachdev Ravi
-
Form 4 STEVEN MADDEN, LTD. For: May 22 Filed by: KLIPPER MITCHELL S
-
Form 4 STEVEN MADDEN, LTD. For: May 22 Filed by: Smith Robert Garrett
-
Form 4 PIONEER MUNICIPAL HIGH For: May 23 Filed by: Saba Capital Management, L.P.
-
Form 4 R1 RCM Inc. /DE For: May 23 Filed by: Speranzo Anthony J
-
Form 4 R1 RCM Inc. /DE For: May 23 Filed by: Armbrester Bradford Kyle
-
Form 4 R1 RCM Inc. /DE For: May 23 Filed by: DILL DAVID M
-
Form 4 MainStay CBRE Global For: May 21 Filed by: Saba Capital Management, L.P.
